The DRD2 gene, smoking, and lung cancer.
Open Access
- 4 March 1998
- journal article
- research article
- Published by Oxford University Press (OUP) in JNCI Journal of the National Cancer Institute
- Vol. 90 (5), 343-345
- https://doi.org/10.1093/jnci/90.5.343
Abstract
Why do some individuals smoke and others do not? Why can some smokers quit, while others cannot? Why do certain smokers develop cancer of the lung, while others, despite prolonged use of cigarettes, do not? These questions have particular relevance during these times when much attention is being focused on the impact of smoking on health throughout the world.Keywords
This publication has 16 references indexed in Scilit:
- Case-Control Study of the D2 Dopamine Receptor Gene and Smoking Status in Lung Cancer PatientsJNCI Journal of the National Cancer Institute, 1998
- Effects of nicotine on the nucleus accumbens and similarity to those of addictive drugsNature, 1996
- D2 dopamine receptor gene and cigarette smoking: A reward gene?Medical Hypotheses, 1994
- Drugs of abuse: anatomy, pharmacology and function of reward pathwaysTrends in Pharmacological Sciences, 1992
- Brain Dopamine and RewardAnnual Review of Psychology, 1989
- Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats.Proceedings of the National Academy of Sciences, 1988
- Nicotine: Abuse Liability, Dependence Potential and Pharmacologic Treatment of DependencePublished by Springer Nature ,1987
- GENETICS OF SMOKING - A BRIEF REVIEWBehavior Therapy, 1986
- Autoradiographic evidence for nicotine receptors on nigrostriatal and mesolimbic dopaminergic neuronsBrain Research, 1985
- The association of smoking and drinking habits in a community sample.Journal of Studies on Alcohol, 1977